ATPC Agape ATP Corp

Nasdaq Services-Health Services NV CIK: 0001713210
AI RATING
STRONG_SELL
92% Confidence

Investment Thesis

Agape ATP Corp is a pre-revenue or minimal-revenue healthcare services company with severe operational losses exceeding revenue by 2x, burning cash at -2.2M annually while generating negative free cash flow. Despite adequate balance sheet liquidity and zero debt, the company's inability to achieve profitability or positive cash generation, combined with negligible revenue growth (0.0% YoY) and worsening per-share economics (-14.5% EPS decline), indicates fundamental business model failure or execution crisis.

Strengths

  • + Strong liquidity position with 16.21x current ratio and minimal liabilities (1.6M vs 24.4M assets)
  • + Zero long-term debt eliminates financial leverage risk and bankruptcy pressure in near term
  • + Positive gross margin of 53.7% indicates underlying unit economics could theoretically work if scaled

Risks

  • ! Operating losses of -2.0M against only 1.1M revenue represents unsustainable 182% burn rate
  • ! Negative operating cash flow of -2.2M annually with -196.3% FCF margin indicates cash runway exhaustion within 12 months at current trajectory
  • ! Revenue stagnation (0.0% YoY growth) with deteriorating per-share metrics (-14.5% EPS decline) suggests failed commercialization or market rejection
  • ! No insider buying activity in last 90 days raises concern about management confidence in turnaround
  • ! Business model unproven: minimal revenue insufficient to validate healthcare services market fit

Key Metrics to Watch

Financial Metrics

Revenue
1.1M
Net Income
-1.9M
EPS (Diluted)
$-0.05
Free Cash Flow
-2.2M
Total Assets
24.4M
Cash
133.7K

Profitability Ratios

Gross Margin 53.7%
Operating Margin -174.1%
Net Margin -169.1%
ROE -8.3%
ROA -7.8%
FCF Margin -196.3%

Balance Sheet & Liquidity

Current Ratio
16.21x
Quick Ratio
16.18x
Debt/Equity
0.00x
Debt/Assets
6.5%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-20T09:18:12.006982 | Data as of: 2025-09-30 | Powered by Claude AI